United Kingdom· GB-APID-34868711000001106
Zanamivir 200mg/20ml solution for infusion vials
A zanamivir product containing zanamivir, registered in United Kingdom by GlaxoSmithKline UK Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Zanamivir is registered in 15 of 19 countries.
Countries holding a registration under ATC J05AH01 (zanamivir), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Zanamivir · ATC J05AH01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Zanamivir
- Manufacturer
- GlaxoSmithKline UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- J05AH01
- ATC class
- Zanamivir
- Defined daily dose
- 20 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
13 interactions on record for zanamivir.
Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zanamivir · interactions on record
13 records
- 5 moderate
- 8 info
Most severe, free to view
- Insulin (human)A10AB01moderate
- Insulin (human)A10AC01moderate
- Insulin (human)A10AD01moderate
- Insulin (human)A10AE01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Zanamivir in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesRELENZAGlaxoSmithKline LLC
- BelgiumDectova 10 mg/mlGlaxoSmithKline Pharmaceuticals
- FinlandDectovaGlaxoSmithKline Trading Services Limited
- IrelandDectova 10 mg/mL solution for infusionGlaxoSmithKline Trading Services Limited
- IcelandDectovaGlaxoSmithKline Trading Services Limited
- NetherlandsDectova 10 mg/ml, oplossing voor infusieGlaxoSmithKline Trading Services Limited
- PolandDectovaGlaxoSmithKline Trading Services Limited
- SwedenDectova 10 mg/ml Infusionsvätska, lösningGlaxoSmithKline Trading Services Ltd
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Relenza Rotadisks
- Belgium · Relenza
- Bulgaria · Реленца
- Germany · Relenza
- Denmark · Relenza
- Spain · Relenza
- Finland · Relenza
- France · Relenza
- Croatia · Relenza
- Ireland · Relenza
- Iceland · Dectova, Relenza
- Italy · Relenza
- Liechtenstein · Dectova
- Luxembourg · Relenza
- Netherlands · Relenza
- Norway · Dectova, Relenza
- Poland · Relenza
- Portugal · Relenza
- Sweden · Relenza
- Slovenia · Relenza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d8b1b4d9-4d30-49d5-a27b-34cb87d31251 GET /v1/drugs/d8b1b4d9-4d30-49d5-a27b-34cb87d31251?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "34868711000001106",
"desc": "Zanamivir 200mg/20ml solution for infusion vials (GlaxoSmithKline UK Ltd)",
"form": "Solution for infusion",
"vpid": "32461911000001103",
"source": "dmd",
"vtm_id": "777969004",
"strength": "10 mg",
"substance": "Zanamivir",
"ingredient": "Zanamivir",
"supplier_code": "4012301000001105"
}See everything about zanamivir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.